Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HLX14 vs Prolia in Healthy Chinese Males
NCT04534582Phase 1Completed
- Sponsor
- Henlius
- Start
- Nov 2020
- Primary completion
- Sep 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of denosumab-nxxp in osteoporosis (6 arms), sponsored by Henlius. Primary endpoints: Area Under the Serum Concentration-Time Curve from Time Zero to Last Quantifiable Time at Day 274, Maximum Serum Concentration at Day 274 and 1 more. Started Nov 2020; status: completed.
02
Drugs
denosumab-nxxp
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT04534582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04534582.